| Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders J Spaas, L Van Veggel, M Schepers, A Tiane, J Van Horssen, ... Cellular and Molecular Life Sciences 78 (10), 4615-4637, 2021 | 152 | 2021 |
| Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis M Schepers, D Paes, A Tiane, B Rombaut, E Piccart, L van Veggel, ... Brain, Behavior, and Immunity 109, 1-22, 2023 | 42 | 2023 |
| Sphingosine-1-phosphate receptor modulators and oligodendroglial cells: beyond immunomodulation A Roggeri, M Schepers, A Tiane, B Rombaut, L van Veggel, N Hellings, ... International journal of molecular sciences 21 (20), 7537, 2020 | 36 | 2020 |
| From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions A Tiane, M Schepers, RA Reijnders, L van Veggel, S Chenine, ... Acta neuropathologica 146 (2), 283-299, 2023 | 12 | 2023 |
| Still in search for an EAAT activator: GT949 does not activate EAAT2, nor EAAT3 in impedance and radioligand uptake assays L van Veggel, TAM Mocking, HJ Sijben, R Liu, M Gorostiola González, ... ACS Chemical Neuroscience 15 (7), 1424-1431, 2024 | 1 | 2024 |
| Insights from an academic endeavor into central nervous system drug discovery L van Veggel, AM Voets, T Vanmierlo, R Schreiber Neural Regeneration Research 20 (6), 1717-1718, 2025 | | 2025 |
| All you can eaat3: Restoring myelin, the brain's favourite fat L van Veggel | | 2024 |
| Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis T VANMIERLO, M SCHEPERS, D PAES, A TIANE, B ROMBAUT, ... Wiley, 2023 | | 2023 |
